Cerus Corp - Company Profile
Powered by
All the data and insights you need on Cerus Corp in one report.
- Save hours of research time and resources with
our up-to-date Cerus Corp Strategy Report
- Understand Cerus Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Cerus Corp (Cerus) is a biomedical products company with focus on developing and commercializing the Intercept blood system to enhance blood safety. The Intercept blood system targets and inactivates blood-borne pathogens in donated blood components intended for transfusion. The company's focused R&D activities, Intercept blood system technology and diverse geographical presence are its strengths, even as a reliance on major customers is a cause for concern to Cerus. Collaborations and agreements, regulatory approvals, and the growing need for safe blood provide the company with immense growth opportunities. However, the competitive environment, lack of manufacturing facilities and safety paradigm are matters of concern to the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward